Acadia Pharmaceuticals
ACAD
ACAD
162 hedge funds and large institutions have $2.33B invested in Acadia Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 20 closing their positions.
Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
24
Increased
50
Reduced
57
Closed
20
Calls
$243M
Puts
$22.1M
Net Calls
+$221M
Net Calls Change
-$54.7M
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Neuberger Berman Group
New York
| – | – | -16,325 | Closed |
|
177
Nomura Holdings
Tokyo,
Japan
| – | – | -16,291 | Closed |
|
|
SCM
178
Stevens Capital Management
Radnor,
Pennsylvania
| – | – | -11,199 | Closed |
|
|
SB
179
Suntrust Banks
Atlanta,
Georgia
| – | – | -10,527 | Closed |
|
|
VFA
180
Virtus Fund Advisers
Hartford,
Connecticut
| – | – | -6,723 | Closed |
|
181
Bank of Montreal
Toronto,
Ontario, Canada
| – | – | -2,160 | Closed |
|
|
FWM
182
Focused Wealth Management
Newburgh,
New York
| – | – | -400 | Closed |
|
|
WAM
183
Wolverine Asset Management
Chicago,
Illinois
| – | – | – | – |
|